Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine. (Q48263540)

10 February 2018

title

Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine. (English)

1 reference

10 February 2018

1 reference

Doudet DJ

1

1 reference

10 February 2018

Chan GL

2

1 reference

10 February 2018

Jivan S

3

1 reference

10 February 2018

DeJesus OT

4

1 reference

10 February 2018

McGeer EG

5

1 reference

10 February 2018

English C

6

1 reference

10 February 2018

Ruth TJ

7

1 reference

10 February 2018

Holden JE

8

1 reference

10 February 2018

publication date

1 March 1999

1 reference

10 February 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

10 February 2018

volume

19

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

278-287

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1097/00004647-199903000-00006

exact match

0 references

cites work

6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

Radiofluorinated L-m-tyrosines: new in-vivo probes for central dopamine biochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

Radiobrominated m-tyrosine analog as potential CNS L-dopa pet tracer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

Distribution and kinetics of 3-O-methyl-6-[18F]fluoro-L-dopa in the rhesus monkey brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

6-[18F]fluoro-L-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

18F‐6‐Fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR‐462)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

Nigrostriatal function in humans studied with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

New rapid analysis method demonstrates differences in 6-[18F]fluoro-l-dopa plasma input curves with and without carbidopa and in hemi-MPTP lesioned monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

4-[18F]fluoro-L-m-tyrosine: an L-3,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199903000-00006

10.1097/00004647-199903000-00006

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

Dimensions Publication ID

0 references

1 reference

10 February 2018